Testing new biomarker tests on pleural biopsies in pleural mesothelioma
Tests a new method to judge stage and outlook in pleural mesothelioma.
Key facts
- Who runs it
- Dana-Farber Cancer Institute
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers
- Status
- Recruiting
- People taking part
- 240 people, planned
- Started
- 31 Oct 2018
- Expected to end
- 1 Oct 2030
- Type of study
- Interventional
- Treatments tested
- MPT Test
- CLDN15/VIM Test
- Record updated
- 5 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with malignant pleural mesothelioma who are having a pleural biopsy, pleuroscopy or VATS surgery.
- Age
- 18 years or older
- Sex
- Men and women can join
- Disease stage
- Malignant pleural mesothelioma, diagnosed
Main reasons for not taking part
- Anyone found to be unsuitable for surgery, treatment or diagnosis
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- All adult patients with a diagnosis of malignant pleural mesothelioma undergoing; diagnostic pleural biopsy; pleuroscopy; and/or VATS resections
- Participants must be 18 years of age or older
Who cannot take part
- surgery,
- -Any patient who is found to be unsuitable for
- treatment
- diagnosis,
Where in United States
- Brigham and Women's HospitalBoston, United StatesContact: Raphael Bueno, MDTaking people
About the trial
What the trial wants to find out
This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.
The group in the trial
- MRiSTreatment being tested
* The specimens to be collected will include at least five pleural biopsy samples * MPT test and the CLDN15/VIM test will be performed
Treatment: MPT Test and CLDN15/VIM Test
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers
- Plain-language title
- Testing new biomarker tests on pleural biopsies in pleural mesotheliomaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 5 May 2026